Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled Study

BACKGROUND: Immunogenicity of tumor necrosis factor alpha inhibitors (TNFis) has been recognized as an important problem that may cause loss of efficacy and adverse events such as infusion reactions. TNFis are being increasingly used among patients with Behçet syndrome (BS) and scarce data exist on...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Esatoglu, Sinem Nihal, Akkoc-Mustafayev, Fatma Nihan, Ozguler, Yesim, Ozbakır, Fatma, Nohut, Okan K., Cevirgen, Dilsen, Hamuryudan, Vedat, Hatemi, Ibrahim, Celik, Aykut Ferhat, Yazici, Hasan, Hatemi, Gulen
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7782473/
https://ncbi.nlm.nih.gov/pubmed/33414791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.618973
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados